A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer
<h3>Background</h3><p dir="ltr">Predictive biomarkers of immune checkpoint inhibitor (ICI) efficacy are currently lacking for non-small cell lung cancer (NSCLC). Here, we describe the results from the Anti–PD-1 Response Prediction DREAM Challenge, a crowdsourced initiativ...
Saved in:
Similar Items
-
Editorial: Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer
by: Said Dermime (79420)
Published: (2021) -
Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects
by: Remy Thomas (702843)
Published: (2021) -
Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer
by: Said Dermime (79420)
Published: (2021) -
Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: recent advances and emerging concepts
by: Naushad Ahmad Khan (6406973)
Published: (2023) -
Immune checkpoint inhibitors: recent progress and potential biomarkers
by: Pramod Darvin (153341)
Published: (2018)